RecruitingNCT07196423
Brain chemistry and thinking after a first psychotic episode
About this title
Read the official source — NCT07196423Study assessmentsAges 18–55United KingdomSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- NottinghamSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 9, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 106
- Sponsor
- University of Nottingham
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device, Diagnostic test
- Locations
- United Kingdom
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT07196423
- Official title
Show the full official title
Glutamate Changes as a New Neurocognitive Marker in Psychosis
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Nottingham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Nottingham, a university.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Culturally adapted CBT for psychosis in Black African and Caribbean people
Clozapine versus usual second-line treatment after a first schizophrenia treatment fails
